Numerate applies big data to drug design

Numerate Trains Its Drug Design Platform On Huntington’s Disease
Bernadette Tansey, xconomy.com

Bernadette TanseyThe path toward a breakthrough drug often starts with a new insight about the molecular cause of an illness, but only a few of these discoveries lead to new treatments. Steven Finkbeiner at the Gladstone Institutes in San…

http://flip.it/Ivquf